If you purchase an independently reviewed product or service through a link on our website, Rolling Stone may receive an affiliate commission. Styles’ running outfits exemplify the sport’s new look.

Officials with the FDA have approvedthe first generic robenacoxib injectable (Robenacoxib Injection; Cronus Pharma Specialties) for the control of postoperative pain and inflammation in canine and ...

Executives from Celldex Therapeutics (NASDAQ:CLDX) outlined a busy year of clinical and development milestones at the TD ...

After months of winter testing, we named the On Running Performance Winter Tight the best all-around men’s running tight for its ultra-comfortable, buttery smooth, stretchy fabric, supportive fit, and ...

Practices Associated with Increased Morbidity. Open Journal of Pediatrics, 16, 258-267. doi: 10.4236/ojped.2026.162027 . Penetrating brain injuries lead to cranio-cerebral wounds through the intrusion ...

Arrowhead Pharmaceuticals (NASDAQ:ARWR) executives outlined a busy slate of clinical catalysts and a growing commercial ...

So welcome to our second IR went in 2026, focusing this time on the Phase III ALLEGORY results for Gazyva in SLE, which just got presented last Friday at SLEuro. Today's call is scheduled for 60 ...

Considering that most companies don't even stay in business for 20 years, finding stocks worth holding onto for good isn't ...

TD Cowen 46th Annual Health Care Conference March 3, 2026 11:10 AM ESTCompany ParticipantsRoopal Thakkar - Executive VP of Research ...

Phase 3 study designed with total hip BMD primary endpoint assessed at 12 months, rather than at 24 months. EB613 single ...

Alaris Equity Partners Income Trust (together, as applicable, with its subsidiaries, "Alaris" or the "Trust") is pleased to announce its results for the three months and year ended December 31, 2025.

ImmunityBio's recently approved cancer drug has plenty of momentum. However, valuation concerns and clinical and regulatory ...